High seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in Perpignan, France
View ORCID ProfileAdeline Beaumont, Cécile Durand, Martine Ledrans, Valérie Schwoebel, Harold Noel, Yann Le Strat, Donatien Diulius, Léa Colombain, Marie Médus, Philippe Gueudet, Damien Mouly, Hugues Aumaître
doi: https://doi.org/10.1101/2021.03.05.21252835
Adeline Beaumont
1Santé Publique France (SpF), Direction des Régions, F-94415 Saint-Maurice, France
Cécile Durand
1Santé Publique France (SpF), Direction des Régions, F-94415 Saint-Maurice, France
Martine Ledrans
2Santé Publique France (SpF), F-94415 Saint-Maurice, France
Valérie Schwoebel
1Santé Publique France (SpF), Direction des Régions, F-94415 Saint-Maurice, France
Harold Noel
2Santé Publique France (SpF), F-94415 Saint-Maurice, France
Yann Le Strat
2Santé Publique France (SpF), F-94415 Saint-Maurice, France
Donatien Diulius
3Agence Régionale de Santé (ARS) Occitanie, Délégation départementale des Pyrénées-Orientales, F-66020 Perpignan, France
Léa Colombain
4Centre Hospitalier de Perpignan, Service des Maladies Infectieuses et Tropicales, F-66046 Perpignan, France
Marie Médus
4Centre Hospitalier de Perpignan, Service des Maladies Infectieuses et Tropicales, F-66046 Perpignan, France
Philippe Gueudet
5Centre Hospitalier de Perpignan, Laboratoire de biochimie et de biologie, F-66046 Perpignan, France
Damien Mouly
1Santé Publique France (SpF), Direction des Régions, F-94415 Saint-Maurice, France
Hugues Aumaître
4Centre Hospitalier de Perpignan, Service des Maladies Infectieuses et Tropicales, F-66046 Perpignan, France
Posted March 08, 2021.
High seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in Perpignan, France
Adeline Beaumont, Cécile Durand, Martine Ledrans, Valérie Schwoebel, Harold Noel, Yann Le Strat, Donatien Diulius, Léa Colombain, Marie Médus, Philippe Gueudet, Damien Mouly, Hugues Aumaître
medRxiv 2021.03.05.21252835; doi: https://doi.org/10.1101/2021.03.05.21252835
High seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in Perpignan, France
Adeline Beaumont, Cécile Durand, Martine Ledrans, Valérie Schwoebel, Harold Noel, Yann Le Strat, Donatien Diulius, Léa Colombain, Marie Médus, Philippe Gueudet, Damien Mouly, Hugues Aumaître
medRxiv 2021.03.05.21252835; doi: https://doi.org/10.1101/2021.03.05.21252835
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (682)
- Anesthesia (183)
- Cardiovascular Medicine (2721)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12369)
- Forensic Medicine (10)
- Gastroenterology (782)
- Genetic and Genomic Medicine (4222)
- Geriatric Medicine (394)
- Health Economics (697)
- Health Informatics (2724)
- Health Policy (1012)
- Hematology (369)
- HIV/AIDS (873)
- Medical Education (403)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4001)
- Nursing (216)
- Nutrition (592)
- Oncology (2108)
- Ophthalmology (601)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1143)
- Primary Care Research (465)
- Public and Global Health (6625)
- Radiology and Imaging (1438)
- Respiratory Medicine (882)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (458)
- Toxicology (57)
- Transplantation (192)
- Urology (171)